Regular UPSC news, every day
‹ News Blitz Science & Technology Developing

India introduces locally developed H5N1 vaccine for chickens

First brief 21 Nov, 5:56 am IST Updated 21 Nov, 5:56 am IST 1 development 3 min read Latest ↓
File: Poultry farm, Namakkal
Matthew T Rader · CC BY-SA 4.0

Where it stands

India introduced a locally developed H5N1 bird-flu vaccine for chickens on 20 November. The Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases developed it in Bhopal. The vaccine targets a particular genetic branch of the virus, called clade 2.3.2.1a. Bird-flu outbreaks can kill poultry and force authorities to destroy exposed flocks to contain infection. Farmers can lose birds, egg production and income together. A vaccine helps chickens develop an immune response before exposure. The government says the new vaccine is intended to strengthen protection against this virus branch and reduce poultry losses. Agriculture Minister Shivraj Singh Chouhan introduced the vaccine and quoted a cost of ₹1–2 per dose. The technical announcement identifies it as an inactivated vaccine, made using virus that has been killed. The announcements describe development and introduction. They give no date for nationwide farm distribution.

Background

Bird flu is influenza infection in birds. Some forms spread rapidly through poultry and cause severe disease. Infection can move between farms through infected birds and contaminated material, making an outbreak costly to contain. H5N1 is a subtype of influenza A virus. Viruses within that subtype continue to change, creating related genetic branches known as clades. Scientists identify the branch circulating in birds because differences between branches can affect how well a vaccine matches the virus. An inactivated vaccine exposes the immune system to killed virus. The bird can then develop a response that helps it recognise the infection. This approach adds vaccination to disease-control work such as monitoring outbreaks and limiting the movement of infected birds. India has recorded more than 500 H5N1 and H5N8 outbreaks together since 2006, according to the institute’s announcement. Repeated outbreaks have meant recurring losses from bird deaths, culling and trade restrictions. The new vaccine addresses that continuing poultry-health problem through a locally developed product.

How it developed

  1. 18 November 2026
    How it started

    Researchers announce a vaccine matched to a virus branch

    The Bhopal institute announced an inactivated H5N1 vaccine for chickens targeting clade 2.3.2.1a. It described the product as India’s first locally developed vaccine for this specific branch. The announcement scheduled its introduction for 20 November.

  2. 20 November 2026
    New fact

    The vaccine is introduced in Bhopal

    The agriculture minister introduced the vaccine at the institute and quoted ₹1–2 per dose. Local development gives India a product designed for the identified virus branch. The announcement does not specify when farms across the country will receive supplies.

Why it matters for UPSC

GS3 · BiotechnologyGS3 · Animal health

For GS3, explain how matching a vaccine to a circulating virus supports animal health and food security. Connect poultry-disease surveillance with farmers’ incomes, vaccine research and outbreak control.

Key terms

Avian influenzaInfluenza infection in birds, commonly called bird flu. Some virus strains cause severe disease in poultry. Outbreaks can disrupt farming through bird deaths, culling and restrictions on moving birds or poultry products.
H5N1A subtype of influenza A virus named after two proteins on its surface: haemagglutinin type 5 and neuraminidase type 1. Different genetic branches can exist within this subtype. The new chicken vaccine targets one such branch.
CladeA group of related organisms or viruses that share a common ancestor. In influenza surveillance, a clade identifies a genetic branch of the virus. The branch targeted by this vaccine is called 2.3.2.1a.
Inactivated vaccineA vaccine made using virus that has been killed. Exposure to the virus material helps the immune system recognise the infection and prepare a response. The new H5N1 product uses this method for chickens.
CullingThe deliberate killing of animals as part of disease control. Authorities may order exposed or infected poultry destroyed to contain an outbreak. Farmers then lose productive birds as well as the income those birds would have generated.
ICAR-NIHSADThe Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases, located in Bhopal. It studies serious animal diseases under specialised containment conditions and developed the chicken vaccine described here.
Sources (3)
Daily news News Blitz Daily quiz Prelims PYQs Live Economic Data Subject notes How to prepare for UPSC Books and NCERTs Syllabus Exam pattern Eligibility and attempts Previous Year Papers Free Downloads Shorts Sign in